Dr Naseem Ali, Medical Affairs Lead for Astellas Australia, said, 'This is especially important as Australia recorded over 26,000 men diagnosed with prostate cancer last year, and we know some of whom will be at high-risk of experiencing BCR."
Astellas' XTANDI achieves landmark survival milestone in prostate cancer
October 21, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus
October 21, 2025 - - Latest News -
FOI reforms set back transparency decades and will impact public health decision-making
October 21, 2025 - - Latest News -
Astellas' XTANDI achieves landmark survival milestone in prostate cancer
October 21, 2025 - - Latest News -
Services Australia reports record number of processed PBS prescriptions
October 21, 2025 - - Latest News -
Endometriosis diagnoses in Australian GP clinics nearly double over a decade
October 21, 2025 - - Latest News -
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - - Latest News -
Vaccine confidence slips as Australians grow more concerned about access to healthcare
October 20, 2025 - - Latest News